The present invention relates to novel human coagulation Factor VIIa variants having coagulant activity as well as polynucleotide constructs encoding such variants, vectors and host cells comprising and expressing the polynucleotide, pharmaceutical compositions, uses and methods of treatment.

 
Web www.patentalert.com

< Rapid and sensitive detection of bacteria in blood products, urine, and other fluids

> Spiroazacyclic compounds as monoamine receptor modulators

~ 00459